Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

Novartis Investigative Site, Riga

Novartis Investigative Site, Vienna

Novartis Investigative Site, Sofia

Novartis Investigational Site, Vienna

Novartis Investigative Site, Ottignies

Novartis Investigative Site, Duffel

Novartis Investigative Site, Tallinn

Johns Hopkins Hospital, Baltimore

University of South Alabama, Mobile

Novartis Investigative Site, Kaunas

Novartis Investigative Site, Tartu

Epilepsy Care Specialists, S.C., Milwaukee

Novartis Investigative Site, Dehli

Novartis Investigative Site, Jaipur

Novartis Investigative Site, Mumbai

Novartis Investigative Site, Bangalore

Novartis Investigative Site, Salzburg

Novartis Investigative Site, Greenfield Park

Novartis Investigative Site, Montreal

Novartis Investigative Site, Riga

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Barcelona